-
Mashup Score: 0Medscape Oncologist Lifestyle & Happiness Report 2024: The Ongoing Struggle for Balance - 4 month(s) ago
Oncologists reveal how they strive for work-life balance, mental health, and family time in their demanding profession. Their diet, exercise, drinking, and online habits are included.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 27Johns Hopkins Receives $1 Billion from Bloomberg, Making Tuition Free for Most Medical Students - 4 month(s) ago
Johns Hopkins University announced on Monday, July 8, that they had received a $1 billion financial gift from Bloomberg Philanthropies for free tuition for medical students from families earning less than $300,000.
Source: PEOPLE.comCategories: General Medicine News, Hem/OncsTweet-
As someone who left med school with 350k in debt, I am so excited for these students. May this gift bring the brightest into medicine to help us solve BIG problems on the horizon. Johns Hopkins Receives $1 Billion from Bloomberg for Free Tuition https://t.co/XZbO9iV9hn
-
-
Mashup Score: 1Opinion: Dear Joe, it’s time to go | CNN - 4 month(s) ago
President Joe Biden risks his legacy and the fate of American democracy if he maintains his candidacy for the 2024 presidential election, writes his former neighbor, Jay Parini.
Source: www.cnn.comCategories: General Medicine News, Hem/OncsTweet-
“The lesson of the late SC Justice Ruth Bader Ginsburg’s desperate effort to cling to power when her resignation, under Obama, would have allowed for a good judge to replace her should be echoing in your head. Don’t be remembered as Joe Bader Biden” https://t.co/2mNqMwjxNt
-
-
Mashup Score: 20A Psychologist Explains The Rise Of ‘Popcorn Brain’ - 6 month(s) ago
Has concentrating on simple tasks been a struggle for you lately? You may be experiencing the all-too-common phenomenon of “popcorn brain.”
Source: www.forbes.comCategories: General Medicine News, Hem/OncsTweet-
“Our attention spans have declined from an average of 2.5 minutes in 2004 to 47 seconds in the last 5-6 years. This not only diminishes productivity but significantly increases stress; the more you switch your attention, the more your stress intensifies.” https://t.co/EIFnrQzMb4
-
-
Mashup Score: 27Join me! | Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs - 6 month(s) ago
Join us for a CME-certified symposium on the role of oral SERDs and next-generation therapeutics in HR-positive/HER2-negative breast cancer. Register now!
Source: clinicaloptions.comCategories: General Medicine News, Hem/OncsTweet-
Join @dradityabardia @VKaklamani and I 6/1 for dinner and lively discussion on novel therapies for HR+ MBC. Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs | CCO https://t.co/3pNAJ5l0ja
-
-
Mashup Score: 1
“There’s a third lane in between cured and terminal.”
Source: www.oprahdaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @Lbackusoncrime: https://t.co/JVORwvjcrN
-
-
Mashup Score: 17A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response - 7 month(s) ago
Xu, Saunders, and Huang et al. generate a large, single-cell RNA sequencing dataset of the breast tumor microenvironment. They use this real-world data atlas to further characterize NK cells and create InteractPrint. InteractPrint is a method that accounts for tumor heterogeneity and accurately predicts response to immunotherapy across breast cancer subtypes.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet-
RT @ithinkichan: Read it here: https://t.co/hBngnwVgqN Happy to talk more- How can we use our lab's tools & data to help you? Led by Lily…
-
-
Mashup Score: 22
Does the addition of the immune checkpoint inhibitor pembrolizumab to standard neoadjuvant chemotherapy improve efficacy in early-stage, high-risk, ERBB2 (formerly HER2)-negative breast cancer?In this analysis of the adaptively randomized phase 2 I-SPY2 …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
After an appreciable amount of adrenal insufficiency lately, it has come to my attention that the incidence is probably more around 8% as seen in ISPY w/ pembrolizumab in BC pts. Important to check cortisol baseline, before surgery and with symptoms. https://t.co/gPTI5q6DHC https://t.co/1k02aMecQ4
-
-
Mashup Score: 3Vaginal Estrogen Therapy Use and Survival in Breast Cancer - 8 month(s) ago
This cohort study compares the mortality risk associated with vaginal estrogen therapy vs no hormone replacement therapy in 2 cohorts of patients with breast cancer in Scotland and Wales.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
RT @Dr_RShatsky: @itsnot_pink @drsarahsam @JaniceTNBCmets Low dose vaginal estrogen is generally considering safe https://t.co/GcAcca0QXs
-
-
Mashup Score: 106
Results of this study showed no evidence of increased early breast cancer-specific mortality in patients who used vaginal estrogen therapy compared with patients who did not use HRT. This finding may provide some reassurance to prescribing clinicians and support the guidelines suggesting that vagina …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
3) Vaginal HRT is OK. There is NO evidence of increased early breast cancer-specific mortality in BC survivors who used vaginal estrogen therapy compared with patients who did not use it. I prescribe it if other things don’t work. Cite: https://t.co/Rcji8apKk8
-
2/3 of oncologists would take a pay cut for better work life balance is a pretty staggering stat. It speaks to the shifts in perspective since the trauma of the pandemic. Medscape Oncologist Lifestyle & Happiness Report 2024 https://t.co/7DcWDO1wVX via @medscape